UK clinical trials - updated daily from ClinicalTrials.gov
Understand the key differences between type 2 diabetes and chronic kidney disease clinical trials and research opportunities
Affects over 4 million people in the UK. GLP-1 receptor agonists and SGLT2 inhibitors have transformed management and are now major trial focus areas.
Affects ~7 million UK adults (mostly undiagnosed early stages). Trials focus on slowing progression, dialysis alternatives, and transplant outcomes.
Diabetes trials are numerous and often focus on cardiovascular/kidney outcomes. CKD trials are harder to recruit for and often study later disease stages.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.
